United States · Investor

Celgene

Last cheque observed Jul 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietGrowth equity

Series BSeries DSeries C

Cheques on record
0%of best year0cheques in 12 months, 33 on record
Since the last cheque2666days00hrs00min00sec
Median round$61MRounds led0 of 33Sole investor8 roundsExits3 from the portfolioMostly inUnited States, 97%
Pitch Celgene

Celgene highlights

  1. 01

    33 rounds on record

  2. 02

    Mostly Series B and Series D: 65% of its rounds

  3. 03

    Sole investor in 8 rounds, median $30M

  4. 04

    3 exits from the portfolio

What they do

Type
Growth equity (from a list, unverified)
Cheque size
Not stated
Based in
San Diego, United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first33 appearances

  1. 2019

    3 rounds

  2. Jul
    GNS HealthcareSeries D · US · FinSMEs$23MWith 5 others
  3. Apr
    Arrakis TherapeuticsSeries B · US · FinSMEs$75MWith 13 others
  4. Feb
    HiberCellSeries A · US · FinSMEs$61MWith 3 others
  5. 2018

    5 rounds

  6. Jul
    Presage BiosciencesSeries D · US · FinSMEs$6.0MWith 1 other
  7. Jun
    SutroSeries E · US · FinSMEs$85MWith 17 others
  8. Mar
    IdeayaSeries B · US · FinSMEs$94MWith 12 others
  9. Feb
    CelularityUS · FinSMEs$250MWith 7 others
  10. Jan
    Ribon TherapeuticsSeries B · US · Marketwatch$65MWith 7 others
  11. 2017

    5 rounds

  12. Dec
    FLX BioSeries C · US · Vcnewsdaily$60MWith 4 others
  13. Aug
    Armo BiosciencesSeries C · US · FinSMEs$67MWith 10 others
  14. Jul
    Evelo BiosciencesSeries B · US · FinSMEs$50MWith 4 others
  15. Mar
    GrailSeries B · US · FinSMEs$900MWith 7 others
  16. Feb
    Arrakis TherapeuticsSeries A · US · FinSMEs$38MWith 4 others
  17. 2016

    2 rounds

  18. Dec
    CotaUS · FinSMEs$18MWith 2 others
  19. Aug
    Cleave BioscienceSeries B · US · FinSMEs$37MWith 2 others
  20. 2015

    1 round

  21. Apr
    CRISPR THERAPEUTICSSeries B · GB$64MWith 5 others
  22. 2014

    6 rounds

  23. Dec
    Flexus BiosciencesSeries B · US$38MWith 2 others
  24. Oct
    SequentaVenture · USUndisclosedSole investor
  25. Sept
    VentiRx PharmaceuticalsSeries B · US$51MWith 4 others
  26. Jun
    NantHealthGrowth · US$25MSole investor
  27. Feb
    EpizymeUS$10MSole investor
  28. Jan
    Atara BiotherapeuticsSeries B · US$14MWith 6 others
  29. 2013

    4 rounds

  30. Dec
    Atara BiotherapeuticsSeries B · US$39MWith 5 others
  31. Dec
    Sutro BiopharmaSeries D · US · finsmes.com$26MWith 5 others
  32. Jul
    Acetylon PharmaceuticalsGrowth · US · bostinno.streetwise.co$100MSole investor
  33. Jul
    TengionSeries D · US · wraltechwire.com$34MSole investor
  34. 2012

    3 rounds

  35. Nov
    Mirna TherapeuticsSeries D · US · sec.gov$17MWith 10 others
  36. Oct
    VentiRx PharmaceuticalsVenture · US · pevc.dowjones.com$35MSole investor
  37. Feb
    Acetylon PharmaceuticalsGrowth · US · finance.yahoo.com$15MSole investor
  38. 2011

    2 rounds

  39. Dec
    Acceleron PharmaSeries F · US · finsmes.com$30MSole investor
  40. Nov
    Agios PharmaceuticalsSeries C · US · finsmes.com$78MWith 3 others
  41. 2010

    1 round

  42. Jun
    FerroKin BiosciencesSeries B · US · fiercebiotech.com$12MWith 4 others
  43. 2007

    1 round

  44. Jan
    Cylene PharmaceuticalsSeries C · US · rctech.com$44MWith 7 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 1 person at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

3+funds on filenumbered funds in its name

Exits from the portfolio

Companies it backed that were later bought or listed3 in all

Flexus BiosciencesBought by Bristol-Myers Squibb$1.3BFeb 2015
SequentaBought by Adaptive BiotechnologiesUndisclosedJan 2015
Agios PharmaceuticalsListed$86MJun 2013

An exit counts when it came after the firm's first round in the company. From historical deal records.

Companies it bought

Acquisitions by the firm itself

Receptos$7.3BJul 2015
Quanticel Pharmaceuticals$485MApr 2015
Avila Therapeutics$350MJan 2012
Abraxis BioScience$2.9BJun 2010
Gloucester Pharmaceuticals$640MDec 2009
Pharmion$2.9BNov 2007

Who they invest alongside

The investors most often in the same rounds as Celgene. A count of rooms they were both in, not a relationship either has claimed.

Alexandria Real Estate EquitiesVC firm5rounds togetherGoogle VenturesCorporate VC5rounds togetherOsage University PartnersVC firm4rounds togetherAmgen VenturesGrowth equity3rounds togetherDAG VenturesVC firm3rounds togetherDomain AssociatesVC firm3rounds togetherKleiner Perkins Caufield & ByersVC firm3rounds togetherPfizerCorporate VC3rounds togetherThe Column GroupVC firm3rounds together6 Dimensions CapitalVC firm2rounds togetherARCH Venture PartnersVC firm2rounds togetherAbingworthVC firm2rounds together

Recently backed

The latest companies Celgene put money into.

Arrakis Therapeutics$75M · Apr 2019HiberCell$61M · Feb 2019Presage Biosciences$6.0M · Jul 2018Celularity$250M · Feb 2018Ribon Therapeutics$65M · Jan 2018Evelo Biosciences$50M · Jul 2017

Quick answers about Celgene

What does Celgene invest in?

Celgene invests most often at Series B and Series D (65% of the rounds on record).

How active is Celgene?

33 investments on record, 0 of them in the last 12 months. The most recent was in Jul 2019.

What has Celgene invested in recently?

Its most recent investments on record: GNS Healthcare (Series D, Jul 2019), Arrakis Therapeutics (Series B, Apr 2019) and HiberCell (Series A, Feb 2019).

How big are Celgene's cheques?

The median round it joins is $61M.

Does Celgene lead rounds?

Rarely, if at all: none of its 33 investments on record names it as the lead.

Where does Celgene invest?

Most of the companies it backs are in the United States (97%).

Is Celgene investing now?

No investments in the last 12 months; the latest was in Jul 2019.

Who does Celgene invest alongside?

Most often Alexandria Real Estate Equities (5 rounds together), Google Ventures (5 rounds together) and Osage University Partners (4 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it